Literature DB >> 30878513

Influence of Glass Forming Ability on the Physical Stability of Supersaturated Amorphous Solid Dispersions.

Lasse Ingerslev Blaabjerg1, Bulut Bulduk1, Eleanor Lindenberg2, Korbinian Löbmann3, Thomas Rades1, Holger Grohganz1.   

Abstract

In this study, the influence of the glass-forming ability (GFA) of a drug on its physical stability in a supersaturated solid dispersion was investigated. Nine drugs were classified according to their GFA using their respective critical cooling rate. Their respective solubility in poly(vinylpyrrolidone-co-vinyl acetate) 6:4 (PVPVA64) was predicted using the melting point depression method based on the Flory-Huggins lattice theory. Supersaturated amorphous solid dispersions at a level of 25% w/w drug above saturation solubility in the polymer were prepared by film-casting, and their respective physical stability at temperatures of 10°C or 20°C above or below their respective Tg (dry conditions) was monitored by the use of polarized light microscopy. This study showed that drugs with good GFA (class 3) on average have higher physical stability in supersaturated amorphous solid dispersion compared to drug with modest GFA (class 2), which in turn have higher physical stability in supersaturated amorphous solid dispersion than drugs with poor GFA (class 1). These results indicate that the GFA of a drug and its physical stability in a supersaturated amorphous solid dispersion stored at a temperature above or below its Tg are correlated.
Copyright © 2019 American Pharmacists Association®. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  amorphous; crystallization; formulation; glass; physical stability; solid dispersion; solid state; solubility

Year:  2019        PMID: 30878513     DOI: 10.1016/j.xphs.2019.02.028

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  4 in total

1.  Myth or Truth: The Glass Forming Ability Class III Drugs Will Always Form Single-Phase Homogenous Amorphous Solid Dispersion Formulations.

Authors:  Piyush Panini; Massimiliano Rampazzo; Abhishek Singh; Filip Vanhoutte; Guy Van den Mooter
Journal:  Pharmaceutics       Date:  2019-10-14       Impact factor: 6.321

2.  Opportunities for Successful Stabilization of Poor Glass-Forming Drugs: A Stability-Based Comparison of Mesoporous Silica Versus Hot Melt Extrusion Technologies.

Authors:  Felix Ditzinger; Daniel J Price; Anita Nair; Johanna Becker-Baldus; Clemens Glaubitz; Jennifer B Dressman; Christoph Saal; Martin Kuentz
Journal:  Pharmaceutics       Date:  2019-11-04       Impact factor: 6.321

3.  Amorphous Solid Dispersions and the Contribution of Nanoparticles to In Vitro Dissolution and In Vivo Testing: Niclosamide as a Case Study.

Authors:  Miguel O Jara; Zachary N Warnken; Robert O Williams
Journal:  Pharmaceutics       Date:  2021-01-14       Impact factor: 6.321

Review 4.  Amorphous solid dispersions: An update for preparation, characterization, mechanism on bioavailability, stability, regulatory considerations and marketed products.

Authors:  Palpandi Pandi; Raviteja Bulusu; Nagavendra Kommineni; Wahid Khan; Mandip Singh
Journal:  Int J Pharm       Date:  2020-06-18       Impact factor: 5.875

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.